Abstract
Background: Infantile hemangiomas (IHs) are the most common vascular tumors of infancy. Topical timolol, a nonselective beta-blocker, has been used for IHs as a safe and effective management option. However, few studies have evaluated the response of topical timolol according to the clinical subtypes of IHs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
